SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-124426
Filing Date
2023-04-28
Accepted
2023-04-28 08:10:37
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d445774d10ka.htm   iXBRL 10-K/A 490909
2 EX-31.3 d445774dex313.htm EX-31.3 3520
3 EX-31.4 d445774dex314.htm EX-31.4 3479
  Complete submission text file 0001193125-23-124426.txt   776575

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atnx-20221231.xsd EX-101.SCH 4970
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atnx-20221231_cal.xml EX-101.CAL 671
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atnx-20221231_def.xml EX-101.DEF 16997
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20221231_lab.xml EX-101.LAB 29928
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20221231_pre.xml EX-101.PRE 18752
10 EXTRACTED XBRL INSTANCE DOCUMENT d445774d10ka_htm.xml XML 6744
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38112 | Film No.: 23860353
SIC: 2834 Pharmaceutical Preparations